Filing Details

Accession Number:
0001123292-16-002364
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-31 15:32:36
Reporting Period:
2016-05-26
Filing Date:
2016-05-31
Accepted Time:
2016-05-31 15:32:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Recro Pharma Inc. REPH Pharmaceutical Preparations (2834) 261523233
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1659872 Stewart Mccallum C/O Recro Pharma, Inc.
490 Lapp Road
Malvern PA 19355
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-26 1,000 $8.15 1,000 No 4 P Direct
Common Stock Acquisiton 2016-05-31 250 $8.50 1,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct